As of Feb 28, 2025
Robo Global Healthcare Technology and Innovation ETF (ARCA: HTEC)
Ticker | Name | Share % | |
---|---|---|---|
STAA | Staar Surgical Co | 2.16% | |
AXGN | Axogen Inc | 2.27% | |
ISRG | Intuitive Surgical Inc | 1.96% | |
ARWR | Arrowhead Pharmaceuticals Inc | 1.84% | |
GH | Guardant Health Inc. | 1.92% | |
VRTX | Vertex Pharmaceuticals Inc | 2.14% | |
NTRA | Natera Inc | 1.78% | |
REGN | Regeneron Pharmaceuticals Common Stock Usd.001 | 1.78% | |
BSX | Boston Scientific Corp. | 2.06% | |
SYK | Stryker Corp | 1.90% | |
TEM | Tempus Ai, Inc. | 2.72% | |
BSX.PR.A | Boston Scientific Corp Pref Series A | 2.15% | |
PEN | Penumbra Inc | 1.97% | |
SG | Siemens Healthineers Ag | 1.90% | |
ALNY | Alnylam Pharmaceuticals Inc. | 1.88% | |
TMO | Thermo Fisher Scientific Inc | 1.97% | |
ABT | Abbott Laboratories | 1.92% | |
PA | Eurofins Scientific Se | 1.91% |
The HTEC ETF is currently trading at $27.48, which represents a -1.48% change. Over the past 52 weeks, the ETF has traded as high as $31.50 and as low as $25.69.
The expense ratio of HTEC is 0.68%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for HTEC is 46.12M. This represents the total market value of the assets managed by the ETF.
HTEC follows a Mid Cap Growth investment style.
The top holdings of HTEC include: STAA (2.16%), AXGN (2.27%), ISRG (1.96%), ARWR (1.84%), GH (1.92%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for HTEC is currently not available.